01 1Centaur Pharmaceuticals
01 1LINAGLIPTIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-09-01
Pay. Date : 2022-08-12
DMF Number : 37163
Submission : 2022-05-30
Status : Active
Type : II
20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINAGLIPTIN, with a corresponding US DMF Number 37163.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 01, 2022, and payment made on August 12, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
